PDS Planning’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
2,414
+105
+5% +$53.1K 0.07% 123
2025
Q4
$1.31M Buy
2,309
+239
+12% +$127K 0.09% 109
2025
Q3
$926K Sell
2,070
-194
-9% -$93.1K 0.06% 141
2025
Q2
$1.23M Buy
2,264
+675
+42% +$353K 0.09% 103
2025
Q1
$787K Buy
1,589
+204
+15% +$113K 0.07% 140
2024
Q4
$723K Buy
1,385
+51
+4% +$26.6K 0.06% 131
2024
Q3
$655K Buy
1,334
+43
+3% +$20K 0.06% 146
2024
Q2
$574K Sell
1,291
-96
-7% -$38.2K 0.06% 146
2024
Q1
$554K Buy
1,387
+44
+3% +$16.6K 0.06% 147
2023
Q4
$453K Buy
1,343
+58
+5% +$17.3K 0.05% 164
2023
Q3
$376K Buy
1,285
+24
+2% +$7.5K 0.05% 175
2023
Q2
$431K Buy
1,261
+214
+20% +$64.7K 0.06% 155
2023
Q1
$267K Buy
1,047
+261
+33% +$64.3K 0.04% 218
2022
Q4
$209K Buy
+786
New +$192K 0.03% 198
2022
Q2
Sell
-702
Closed -$212K 233
2022
Q1
$212K Buy
+702
New +$205K 0.04% 200

Other funds holding ISRG

PDS Planning's ISRG Position: Q1 2026 in Review

PDS Planning increased its Intuitive Surgical (ISRG) stake by 4.5% in Q1 2026, buying an estimated $53.1K and bringing the position to 2,414 shares worth $1.11M. The position accounts for 0.07% of the portfolio, ranked #123.

PDS Planning first reported a position in ISRG in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.31M in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • PDS Planning held 2,414 shares of Intuitive Surgical worth $1.11M as of Q1 2026.
  • PDS Planning bought 105 Intuitive Surgical shares in Q1 2026, an estimated $53.1K.
  • Intuitive Surgical made up 0.07% of PDS Planning's portfolio in Q1 2026, its #123 holding.
  • PDS Planning first reported a position in Intuitive Surgical in Q1 2022 and has held it in 15 quarters since.
  • PDS Planning's Intuitive Surgical position peaked at $1.31M in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.